Search research articles
Contact Us
Filters
Showing results (1-10 of 235) with videos related to
Page
of 24
Sort By:
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
May 31, 1994
HPV genotype as a prognostic factor for progression to cervical carcinoma in young women
P Kenemans
Journal of Epidemiology and Biostatistics
|
March 1, 2000
Menopause, HRT and menopausal symptoms
P Kenemans
Maturitas
|
February 15, 2001
Tissue specificity of sex hormones and so-called modulation of receptors and enzymes
P Kenemans
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
May 31, 1994
Gestational trophoblastic disease: management, the European way
P Kenemans
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
September 1, 1990
CA 125 and OA 3 as target antigens for immunodiagnosis and immunotherapy in ovarian cancer
P Kenemans
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
July 1, 1996
Hormone replacement therapy and breast cancer
P Kenemans, M Stampfer
Best Practice & Research. Clinical Endocrinology & Metabolism
|
May 24, 2003
Breast cancer and post-menopausal hormone therapy
P Kenemans, A Bosman
Maturitas
|
May 11, 2005
Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group
P Kenemans, L Speroff,
Current Opinion in Obstetrics & Gynecology
|
March 4, 1998
Postmenopausal hormone replacement therapy and cancer of the female genital tract and breast
C W Burger, P Kenemans
Nederlands Tijdschrift Voor Geneeskunde
|
January 21, 1984
[6 clinical conditions caused by one kind of ovarian tumor]
J P Lips, P Kenemans
Page
of 24
Search research articles
Search
Showing results (1-10 of 235) with videos related to
Sort By:
Page
of 24
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
May 31, 1994
HPV genotype as a prognostic factor for progression to cervical carcinoma in young women
P Kenemans
Journal of Epidemiology and Biostatistics
|
March 1, 2000
Menopause, HRT and menopausal symptoms
P Kenemans
Maturitas
|
February 15, 2001
Tissue specificity of sex hormones and so-called modulation of receptors and enzymes
P Kenemans
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
May 31, 1994
Gestational trophoblastic disease: management, the European way
P Kenemans
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
September 1, 1990
CA 125 and OA 3 as target antigens for immunodiagnosis and immunotherapy in ovarian cancer
P Kenemans
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
July 1, 1996
Hormone replacement therapy and breast cancer
P Kenemans, M Stampfer
Best Practice & Research. Clinical Endocrinology & Metabolism
|
May 24, 2003
Breast cancer and post-menopausal hormone therapy
P Kenemans, A Bosman
Maturitas
|
May 11, 2005
Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group
P Kenemans, L Speroff,
Current Opinion in Obstetrics & Gynecology
|
March 4, 1998
Postmenopausal hormone replacement therapy and cancer of the female genital tract and breast
C W Burger, P Kenemans
Nederlands Tijdschrift Voor Geneeskunde
|
January 21, 1984
[6 clinical conditions caused by one kind of ovarian tumor]
J P Lips, P Kenemans
Page
of 24